Table 1 Baseline characteristics of the study population.

From: Proteinuria Detected by Urine Dipstick Test as a Risk Factor for Atrial Fibrillation: A Nationwide Population-Based Study

Characteristics

Proteinuria by Dipstick test

Total

Negative

Trace ( ± )

1+

2+

3+

4+

(N = 18,201,275)

(N = 17,611,940)

(N = 270,707)

(N = 214,883)

(N = 83,251)

(N = 17,386)

(N = 3,108)

Age

45.3 ± 14.6

45.2 ± 14.6

47.1 ± 14.9

49.5 ± 15.1

51.1 ± 15

52.2 ± 14.7

52.7 ± 14.8

Age group

  <45 years

9,117,474 (50.1)

8,883,857 (50.4)

119,872 (44.3)

80,439 (37.4)

27,321 (32.8)

5,109 (29.4)

876 (28.2)

  45–64 years

7,055,518 (38.8)

6,795,612 (38.6)

113,469 (41.9)

97,099 (45.2)

39,287 (47.2)

8,539 (49.1)

1,512 (48.7)

  ≥65 years

2,028,283 (11.1)

1,932,471 (11.0)

37,366 (13.8)

37,345 (17.4)

16,643 (20.0)

3,738 (21.5)

720 (23.2)

Sex category (Female)

8,508,841 (46.7)

8,228,925 (46.7)

128,619 (47.5)

103,563 (48.2)

38,646 (46.4)

7,739 (44.5)

1,349 (43.4)

Height (cm)

163.5 ± 9.2

163.5 ± 9.2

163.2 ± 9.2

162.5 ± 9.1

162.4 ± 9.1

162.3 ± 9.0

162.3 ± 9.0

Body weight (kg)

63.1 ± 11.4

63.1 ± 11.3

63.8 ± 11.8

64.1 ± 12.1

64.5 ± 12.4

64.6 ± 12.4

64.8 ± 12.3

Body mass index (kg/m2)

23.5 ± 3.3

23.5 ± 3.2

23.9 ± 3.4

24.2 ± 3.5

24.4 ± 3.7

24.4 ± 3.7

24.5 ± 3.8

  −18.5

788,860 (4.3)

762,830 (4.3)

11,970 (4.4)

9,424 (4.4)

3,735 (4.5)

780 (4.5)

121 (3.9)

  18.5–23

7,453,845 (41.1)

7,248,747 (41.2)

100,399 (37.1)

72,093 (33.6)

26,219 (31.5)

5,401 (31.1)

986 (31.7)

  23–25

4,409,486 (24.2)

4,272,571 (24.3)

63,800 (23.6)

49,595 (23.1)

18,847 (22.6)

3,964 (22.8)

709 (22.8)

  25–30

4,995,496 (27.5)

4,805,162 (27.3)

82868 (30.6)

71,583 (33.3)

28,846 (34.7)

5,989 (34.5)

1,048 (33.7)

  30-

553,588 (3.0)

522,630 (3.0)

11,670 (4.3)

12,188 (5.7)

5,604 (6.7)

1,252 (7.2)

244 (7.9)

Systolic blood pressure (mmHg)

123.4 ± 16.6

123.2 ± 16.2

125.2 ± 17.7

128.6 ± 19.1

131.5 ± 20

134 ± 20.6

134.3 ± 21.1

Diastolic blood pressure (mmHg)

77.1 ± 10.9

77 ± 10.7

78 ± 11.5

79.8 ± 12

81.2 ± 12.3

82.1 ± 12.5

81.8 ± 12.6

Smoking status

  Never smoker

11,989,926 (66.0)

11,595,519 (65.8)

179,653 (66.4)

145,118 (67.5)

55,954 (67.2)

11,617 (66.8)

20,65 (66.4)

  Ex-smoker

1,488,847 (8.2)

1,437,165 (8.2)

23,468 (8.7)

18,557 (8.6)

7,702 (9.3)

1,647 (9.5)

308 (9.9)

  Current smoker

4,722,502 (26.0)

4,579,256 (26.0)

67,586 (25.0)

51,208 (23.8)

19,595 (23.5)

4,122 (23.7)

735 (23.7)

Alcohol drinking

  Complete or near abstinence

9,490,024 (52.1)

9,169,243 (52.1)

142,596 (52.7)

118,856 (55.3)

47,212 (56.7)

10,260 (59.0)

1,857 (59.8)

Moderate consumption

  (≤4 glasses per week)

3,023,297 (16.6)

2,937,260 (16.7)

41,935 (15.5)

30,230 (14.1)

11,291 (13.6)

2,207 (12.7)

374 (12.0)

Heavy drinking

  (≥5 glasses per week)

5,687,954 (31.3)

5,505,437 (31.3)

86,176 (31.8)

65,797 (30.6)

24,748 (29.7)

4,919 (28.3)

877 (28.2)

Exercise

  No

10,009,473 (55.0)

9,688,062 (55.0)

145,150 (53.6)

118,756 (55.3)

46,133 (55.4)

9,647 (55.5)

1,725 (55.5)

  1–4 times a week

6,699,138 (36.8)

6,489,208 (36.9)

100,123 (37.0)

74,701 (34.8)

28,229 (33.9)

5,848 (33.6)

1,029 (33.1)

  5–7 times a week

1,492,664 (8.2)

1,434,670 (8.2)

25,434 (9.4)

21,426 (10.0)

8,889 (10.7)

1,891 (10.9)

354 (11.4)

Comorbidities

  Hypertension

5,216,608 (28.7)

4,954,357 (28.1)

100,006 (36.9)

101,722 (47.3)

47,273 (56.8)

11,215 (64.5)

2,035 (65.5)

  Diabetes

1,636,476 (9.0)

1,513,221 (8.6)

40,662 (15.0)

49,507 (23.0)

25,145 (30.2)

6,633 (38.2)

1,308 (42.1)

  Dyslipidemia

2,754,129 (15.1)

2,609,021 (14.8)

55,882 (20.6)

54,806 (25.5)

26,246 (31.5)

6,834 (39.3)

1,340 (43.1)

  Ischemic heart disease

457,659 (2.5)

428,605 (2.4)

10,190 (3.8)

11,083 (5.2)

5,903 (7.1)

1,546 (8.9)

332 (10.7)

  History of MI

130,590 (0.7)

122,971 (0.7)

2,712 (1.0)

2,864 (1.3)

1,528 (1.8)

427 (2.6)

88 (2.8)

  Congestive heart failure

109,719 (0.6)

102,512 (0.6)

2,341 (0.9)

2,772 (1.3)

1,529 (1.8)

457 (2.6)

108 (3.5)

  History of stroke

184,509 (1.0)

172,012 (1.0)

4,315 (1.6)

5,014 (2.3)

2,408 (2.9)

633 (3.6)

127 (4.1)

  COPD

961,643 (5.3)

922,628 (5.2)

16,087 (5.9)

14,767 (6.9)

6,413 (7.7)

1,454 (8.4)

294 (9.5)

Follow-up (years)

9.6 ± 1.9

9.6 ± 1.9

9.4 ± 2.0

9.2 ± 2.2

9 ± 2.4

8.7 ± 2.7

8.4 ± 2.8

  1. Values are n (%) or mean ± SD.
  2. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.